BridgeMD
New treatment option for Trigeminal Neuralgia (TN)
Official title Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN
ClinicalTrials.gov ID: NCT06949436
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate Gamma Knife stereotactic radiosurgery (GK-SRS) as an ultra-early treatment option for trigeminal neuralgia (TN). The main questions it aims to answer are: 1.
- Phase 2: a mid-size study of how well it works
- Time commitment: about 10 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years
- Clinical diagnosis of classical or idiopathic TN, based on clinical history and MRI scan
- Clinical diagnosis within 2 years prior to enrolment
- Not deemed medically refractory (defined as adequate pain control despite ≥2 medication trials of adequate dose. Adequate pain control is defined as...
- If currently on medication, on stable dose x at least 3 months
You likely can't join if
- Secondary TN
- Bilateral TN
- Any contraindications to undergoing GK-SRS
- Any prior cranial radiation
- Any prior surgical intervention for TN
- History of psychiatric diagnoses within 2 years of study participation, or uncontrolled, concurrent psychiatric illness (e.g., depression with recent...
See the full eligibility criteria
- Age ≥18 years
- Clinical diagnosis of classical or idiopathic TN, based on clinical history and MRI scan
- Clinical diagnosis within 2 years prior to enrolment
- Not deemed medically refractory (defined as adequate pain control despite ≥2 medication trials of adequate dose. Adequate pain control is defined as pain that is considered acceptably controlled by both the patient and...
- If currently on medication, on stable dose x at least 3 months
- Secondary TN
- Bilateral TN
- Any contraindications to undergoing GK-SRS
- Any prior cranial radiation
- Any prior surgical intervention for TN
- History of psychiatric diagnoses within 2 years of study participation, or uncontrolled, concurrent psychiatric illness (e.g., depression with recent suicide attempts)
- Females who are pregnant or breast-feeding
The study team makes the final eligibility decision.
Where it's taking place
- Edmonton, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edmonton, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.